This presentation examines the evolving regulatory landscape of clinical research compliance, emphasizing how multiple federal and state agencies—beyond the FDA—are shaping enforcement priorities in the clinical trial space.
This program focuses on the legal framework and regulatory requirements governing the advertising and promotion of prescription drugs under the Food, Drug, and Cosmetic Act (FDCA).
This program will help attorneys representing clients who suffer from a substance abuse disorder understand the issues and causes of action arising from their poor and inadequate treatment.
This program will give viewers an overview of the Anti-Kickback, Stark and False Claims Acts, which are intended to ensure that healthcare providers’ judgments are not compromised by improper financial incentives.
This course will explore product liability lawsuits filed against cosmetic companies for failure to warn consumers about a link to reproductive health problems.